Digital technology for anaphylaxis management impact on patient behaviour: A randomized clinical trial

Autor: Victoria Cardona, Anna Sala-Cunill, Moises Labrador-Horrillo, Adrian Curran, Nuria Moreno, Mónica Gonzalez-Medina, Olga Luengo, Paula Galvan-Blasco, Mar Guilarte
Rok vydání: 2020
Předmět:
Zdroj: Allergy. 76:1507-1516
ISSN: 1398-9995
0105-4538
Popis: BACKGROUND Epinephrine is the first-line treatment for anaphylaxis. Patients at risk should always carry an epinephrine autoinjector (EAI). Several EAI gaps have been identified. We sought to evaluate satisfaction using a medical device (digital technology comprising an EAI smart case connected to a mobile APP) with functions that overcome most of the EAI limitations and to determine whether patient behaviour and anaphylaxis management improve with its use. METHODS This was a randomized, open-label, crossover clinical trial in a tertiary hospital involving patients with history of anaphylaxis carrying an EAI. The study was conducted in two three-month periods, one with and one without the medical device. The primary endpoint was satisfaction with the medical device. Usability, adherence, anxiety and anaphylaxis episodes were evaluated as secondary endpoints. RESULTS A total of 100 patients were included (mean age 38.1 years, 74% female), and 95 completed the trial. The satisfaction visual analogue scale (VAS) after using the medical device was higher than before its use (89.1 [95% CI, 60.2-99.1] vs 56.3 [95% CI, 48.1-81.4]; P
Databáze: OpenAIRE